Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value calculation as at 31 March 2026

18 May 2026 07:00

RNS Number : 5690E
Agronomics Limited
18 May 2026
 

 

18 May 2026

Agronomics Limited

("Agronomics" or the "Company")

Net Asset Value calculation as at 31 March 2026

Agronomics Limited (AIM:ANIC), a leading listed company in the field of clean food, announces that its unaudited Net Asset Value per share ("NAV") calculation as at closing on 31 March 2026 was 13.12 pence per share, a 4.8% decrease from 13.78 pence per share at 31 December 2025. Net Assets stand at £139 million, including investments of £138 million and uninvested cash and short-term deposits of £1.9 million.

The share price of 6.32 pence at 31 March 2026 represents a discount of 52% to the NAV per share on the same date. The average discount to NAV per share over the last 12-month period was 50%. Under IFRS, the Company's unquoted investments are generally carried at cost or the most recent priced funding round.

The £1.3 million decrease in the Company's NAV during the quarter which relates primarily to the following:

- An unrealised FX gain of £2.1 million following revaluation of investments to month end spot rate, where we hold certain of our investments in USD, EUR and AUD, due to positive movements in these currencies against the Company's reporting currency of Pound Sterling in the quarter;

- Unrealised fair value losses on the investment held in Solar Foods Oy, with its shares traded on the Nasdaq First North Growth Exchange, of £0.12 million; and

- Cash balances reduced by £0.3 million relating to ongoing running costs. This is offset by interest income earned during the quarter, with £10k cash interest received and £35k loan note interest income accrued.

Cash and deposit balances at 31 March 2026 were £1.9 million (31 December 2025: £2.1 million)

During the period, no fees were payable or accrued in accordance with the Shellbay Investments Limited Agreement. Shellbay's fees are only payable when there is an annual increase in the NAV; further details are included in the 2025 annual report.

Investment Portfolio review

During the 3-month period to 31 March 2026, two portfolio companies successfully completed fundraises:

· 15 January 2026 - Agronomics made an additional investment of AU$3 million (c.£1,468,860) in All G Co Holdings Pty Limited via a Note Purchase Agreement, as part of a minimum AU$10 million funding round. The consideration was satisfied in full by the issue of 10,026,375 new Ordinary Shares of Agronomics at 14.65 pence per share. Capital raised will be used primarily to scale up commercial production, advance additional regulatory submissions, strengthen the company's IP portfolio, and expand commercial activities across Asia and Europe.

· 19 March 2026 - Tropic Biosciences UK Limited closed a US$105 million Series C financing round, co-led by Forbion through its Bioeconomy Fund and Corteva through its Corteva Catalyst investment platform, with participation from Just Climate, IQ Capital, ABN AMRO, Invest International, Temasek, Five Seasons Ventures, Sucden Ventures, Genoa Ventures and Polaris Partners. The capital will be used to accelerate the global commercial scale up of Tropic's banana and rice portfolios, advance the pipeline of their climate-resilient crops and to expand large-scale plant production.

The following key milestone was achieved by our portfolio company during the 3-month period:

· 25 March 2026 - Clean Food Group announced the commercial launch of CLEANOil™, its biotechnology-derived ingredient platform for the beauty industry, ahead of its debut at in-cosmetics Global in Paris. The launch, achieved through collaboration with beauty manufacturer THG Labs, marks the progression of CLEANOil™ from concept to commercial reality.

 

Jim Mellon, Executive Chair of Agronomics, commented:

"The first quarter of the year was an encouraging reminder that the clean food sector continues to produce companies capable of attracting serious, long-term capital. While much of the wider market remains cautious, the businesses with credible technology and a clear route to commercialisation are still finding strong support. During the period, Tropic's US$ 105 million Series C demonstrated the appetite that exists for proven, scalable platforms addressing genuine challenges in global food and agriculture, while Clean Food Group's commercial launch of CLEANOil™ with THG Labs represents a concrete step from development into the market. These are tangible, operational developments, and they reinforce our belief that the companies best positioned to lead are those translating scientific capability into commercial outcomes."

 

 

Unaudited to 31 March 2026

£

Current Assets

 

 

 

Investments

136,793,745

 

Uninvested cash and deposits

1,872,462

 

Trade and other receivables

88,627

Current Liabilities

 

 

 

Trade and other creditors

(105,905)

Net Assets

 

138,648,929

Capital and Reserves

 

 

 

Share capital

1,056

 

Share premium

143,113,652

 

Retained earnings

(4,465,779)

Net assets

 

138,648,929

Shares in Issue

 

 

Net Asset Value per share

 

13.12 pence

 

The quoted investments within the portfolio are valued under IFRS at bid price.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

About Agronomics

Agronomics is a leading London-listed company focusing on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information please contact:

Agronomics Limited

Beaumont Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

33Seconds Limited

 

The Company

 

Nomad

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

 

Giles Balleny

Michael Johnson

 

Jack Ferris

Amber Carr

 

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

agronomics@33seconds.co

 

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBBGDUGDBDGLU
Date   Source Headline
8th Feb 20237:00 amRNSUnaudited Interim Results
7th Feb 20234:49 pmRNSInvestee Company Update: CellX
2nd Feb 202311:04 amRNSResult of AGM
25th Jan 20237:00 amRNSNet Asset Value calculation at 31 December 2022
25th Jan 20237:00 amRNSInvestee company Update: Liberation Labs
4th Jan 20237:00 amRNSPerformance Shares issued to Shellbay Investments
30th Dec 202212:00 pmRNSPortfolio Company Update: Liberation Labs
23rd Dec 20227:00 amRNSSolar Foods receives Euro34 million in grant
20th Dec 20229:00 amRNSFinal Results
5th Dec 20229:18 amRNSInvestee Company Update: Clean Food Group
5th Dec 20227:00 amRNSFurther Investment in Liberation Labs Seed Round
28th Nov 20227:00 amRNSHolding(s) in Company
23rd Nov 20225:59 pmRNSHolding(s) in Company
17th Nov 20227:30 amRNSFirst Cultivated Meat Company gets FDA approval
3rd Nov 20227:00 amRNSAgronomics Capital Markets Day 3rd November
27th Oct 202212:02 pmRNSDirector Dealings
26th Oct 20229:30 amRNSPortfolio Company Solar Foods Update
20th Oct 20227:00 amRNSInvestment in Liberation Labs US$ 20m fundraise
19th Oct 20229:00 amRNSAgronomics October 2022 Newsletter
19th Oct 20227:00 amRNSNet Asset Value calculation to 30 September 2022
12th Oct 20228:53 amRNSHolding(s) in Company
11th Oct 20227:00 amRNSExercise of Warrants & TVR
10th Oct 20227:00 amRNSPortfolio Company Meatable Update
6th Oct 20227:00 amRNSPortfolio Company VitroLabs Update
26th Sep 20228:48 amRNSEdison issues flash on Agronomics (ANIC)
21st Sep 20227:00 amRNSPortfolio Company Update: Onego Bio
21st Sep 20227:00 amRNSAgronomics Capital Markets Day 3rd November
8th Sep 20227:00 amRNSPortfolio Update: Bond Pet Foods Completes Funding
7th Sep 20227:00 amRNSPortfolio Company Onego Bio Awarded Grant Funding
11th Aug 20227:00 amRNSEdison issues update on Agronomics (ANIC)
4th Aug 20227:00 amRNSAgronomics Leads All G Foods Series A Financing
1st Aug 20227:00 amRNSAgronomics Leads Clean Food Group’s Seed Financing
25th Jul 20224:40 pmRNSSecond Price Monitoring Extn
25th Jul 20224:35 pmRNSPrice Monitoring Extension
22nd Jul 20227:00 amRNSNet Asset Value calculation to 30 June 2022
20th Jul 20229:03 amRNSPortfolio Company Update: Meatable
18th Jul 202212:24 pmRNSAgronomics July 2022 Newsletter
14th Jul 20227:00 amRNSAppointment of Joint Corporate Broker
8th Jul 202212:29 pmRNSInvestee Company Update: Tropic Biosciences
5th Jul 20227:00 amRNSExercise of Warrants and Total Voting Rights
20th Jun 20227:00 amRNSFinancing of Liberation Labs with CPT Capital
16th May 20229:52 amRNSHolding(s) in Company
6th May 20227:00 amRNSAgronomics Follow-on Investment in CellX
4th May 20229:00 amRNSPortfolio Company VitroLabs completes financing
25th Apr 20227:00 amRNSIssue of Performance Shares & Directors' Dealings
22nd Apr 20227:00 amRNSNet Asset Value calculation to 31st March 2022
5th Apr 20221:25 pmRNSExercise of Warrants, Total Voting Rights
23rd Mar 20229:30 amRNSAnnounces the Trading Facility of Warrants
21st Mar 20228:00 amRNSLaunch of Cultivated Meat Pet Food Venture
18th Mar 20227:00 amRNSANIC Joins the Alternative Proteins Association

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.